Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Talmipure-MT Tablet ER

Prescription Icon
Prescription Required

Marketer

Ampure Pharmaceutical LLP

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Talmipure-MT Tablet ER

Talamine XR is prescribed for hypertension management. Its blood pressure-lowering action reduces the risk of future cardiac events, such as strokes and heart attacks, improving survival odds in heart attack patients. Consistent blood levels are achieved by taking Talamine XR with food at the same time daily, as directed by your physician. Continuous use, even when feeling well, is crucial as hypertension is often asymptomatic; premature discontinuation can worsen the condition. A healthy lifestyle, including regular exercise, weight management, and a balanced diet, complements this medication's effects. Closely follow your doctor's instructions. Potential side effects may include headache, weakness, dizziness, hypotension (occasionally with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Potassium-rich foods and supplements should be avoided. Dizziness may occur; avoid driving and rise gradually from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolyte levels may be required. Inform your doctor about any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical counsel before commencing treatment. Always disclose all current medications, particularly those for hypertension or heart ailments.

Uses of Talmipure-MT Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Talmipure-MT Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Talmipure-MT Extended-Release tablets should be taken with a meal.

Common Side effects of Talmipure-MT Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Talmipure-MT Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Talmipure-MT Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this medicine with food.

How Talmipure-MT Tablet ER works:

Each Talmipure-MT Extended-Release tablet contains Telmisartan and Metoprolol Succinate, two medications that work together to reduce high blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Talmipure-MT Tablet ER and alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Talmipure-MT tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Talmipure-MT tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Talmipure-MT tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is discouraged if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Talmipure-MT tablets pose no safety concerns for individuals with renal impairment; dose modification is unnecessary.

LiverLiverCAUTION

Extended-release Talmipure-MT tablets require careful administration for individuals with hepatic impairment. Dosage modification of Talmipure-MT extended-release tablets might be necessary. Physician consultation is recommended.

What if you forget to take Talmipure-MT Tablet ER :

Should you forget a Talmipure-MT Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Talmipure-MT Tablet ER

LabelValue
Addictive None.
Type of Medication HEART

FAQs on Talmipure-MT Tablet ER

Indeed, dizziness is a potential side effect of Talmipure-MT Extended-Release Succinate tablets. This symptom may manifest upon standing after a period of recumbency. To mitigate the risk of dizziness or fainting, stand gradually after sitting or lying down.
Adopting a healthier lifestyle complements the use of Talmipure-MT Tablet ER Succinate. Smoking cessation is crucial, as it significantly elevates the risk of cardiovascular events such as heart attack and stroke. Weight management is essential for those who are overweight or obese. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and mitigates the likelihood of heart attack.
Continue taking Talmipure-MT Tablet ER as directed by your physician, even if you feel healthy. Abrupt cessation of Talmipure-MT Tablet ER can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Talmipure-MT Tablet ER
121
MRP 148
18% off